Interaction of certain monoterpenoid hydrocarbons with the receptor binding domain of 2019 novel coronavirus (2019-nCoV), transmembrane serine protease 2 (TMPRSS2), cathepsin B, and cathepsin L (CatB/L) and their pharmacokinetic properties

As of June 2020, the coronavirus disease 19 (COVID-19) caused by the 2019 new type coronavirus (2019-nCoV) infected more than 7,000,000 people worldwide and caused the death of more than 400,000 people. The aim of this study was to investigate the molecular interactions between monoterpenoids and spike protein of 2019-nCoV together with the cellular proteases [transmembrane serine protease 2 (TMPRSS2), cathepsin B (CatB), and cathepsin L (CatL)]. As a result of the relative binding capacity index (RBCI) analysis, carvone was found to be the most effective molecule against all targets when binding energy and predicted (theoretical) IC50 data were evaluated together. It was found to exhibit drug-likeness property according to the Lipinski’s rule-of-five. Carvone has also been determined to be able to cross the blood-brain barrier (BBB) effectively, not a substrate for P-glycoprotein (P-gp), not to inhibit any of the cytochrome P molecules, and to have no toxic effects even on liver cells. In addition, the LD50 dose of carvone in rats was 1.707 mol/kg. Due to its interaction profile with target proteins and excellent pharmacokinetic properties, it has been concluded that carvone can be considered as an alternative agent in drug development studies against 2019-nCoV.

___

  • Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
  • Thuy BTP, 2020, ACS OMEGA, V5, P8312, DOI 10.1021/acsomega.0c00772
  • Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
  • Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
  • COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916
  • Corman VM, 2019, INTERNIST, V60, P1136, DOI 10.1007/s00108-019-00671-5
  • Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382
  • Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
  • de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
  • EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
  • Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152
  • Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10
  • Greenspan PD, 2001, J MED CHEM, V44, P4524, DOI 10.1021/jm010206q
  • Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
  • Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
  • Hardegger LA, 2011, CHEMMEDCHEM, V6, P2048, DOI 10.1002/cmdc.201100353
  • Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
  • Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
  • LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
  • Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
  • Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
  • Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
  • Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
  • Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10
  • Morris Garrett M., 2008, V443, P365, DOI 10.1007/978-1-59745-177-2_19
  • Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929
  • Nasab RR, 2017, RES PHARM SCI, V12, P425, DOI 10.4103/1735-5362.213988
  • Nguyen PH, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2020.113813
  • Pagliaro M., 2020, ACCELERATED PRODUCTI, DOI [10.20944/preprints202003.0386.v1, DOI 10.20944/PREPRINTS202003.0386.V1]
  • Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2
  • Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104
  • Prakash D, 2007, INT J FOOD SCI NUTR, V58, P18, DOI 10.1080/09637480601093269
  • Rac A, 2020, DATA BRIEF, V28, DOI 10.1016/j.dib.2019.105038
  • Ramirez D, 2018, MOLECULES, V23, DOI 10.3390/molecules23051038
  • Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]
  • Rettie AE, 2005, ANNU REV PHARMACOL, V45, P477, DOI 10.1146/annurev.pharmtox.45.120403.095821
  • Ricci CG, 2009, J CHEM INF MODEL, V49, P1925, DOI 10.1021/ci9001537
  • Sampangi-Ramaiah MH, 2020, CURR SCI INDIA, V118, P1087, DOI 10.18520/cs/v118/i7/1087-1092
  • Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
  • Sharma S., 1996, 2 GROUP DISCRIMINATN .
  • Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10
  • Singh BN, 2009, FOOD CHEM TOXICOL, V47, P1161, DOI 10.1016/j.fct.2009.02.004
  • Singh BN, 2009, FOOD CHEM TOXICOL, V47, P1109, DOI 10.1016/j.fct.2009.01.034
  • Singh BN, 2009, FOOD CHEM TOXICOL, V47, P778, DOI 10.1016/j.fct.2009.01.009
  • Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057
  • Smith M, 2020, REPURPOSING THEREPEU, DOI [10.26434/chemrxiv.11871402, DOI 10.26434/CHEMRXIV.11871402]
  • Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020
  • Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828
  • Tallei T. E., 2020, POTENTIAL PLANT BIOA, DOI [10.20944/preprints202004.0102.v1, 10.20944/preprints202004.0102.v2, DOI 10.20944/PREPRINTS202004.0102.V1]
  • Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
  • Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066
  • Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312
  • Zar J, 1996, BIOSTATISTICAL ANAL .
  • Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017